AN2 Therapeutics stock price
AN2 테라퓨틱스NASDAQ:ANTX · Nasdaq · HealthcareToday's signals · Golden cross, MACD bullish cross
Signal details →AN2 Therapeutics last closed at $5.71 (+1.60%) on 2026-10-02. Signals today: Golden cross, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -7.0×. Its overall grade ranks 180 of 739 stocks in Healthcare.
About this company
AN2 Therapeutics last closed at $5.71 (+1.60%) on 2026-10-02. Signals today: Golden cross, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 180/739
Valuation grade A
Related stocks
- GlaxoSmithKlineCompetitor
혈청음성 전신성 중증 근무력증 등 자가면역·면역질환 치료제 시장에서 경쟁 가능
- UCBCompetitor
중증 근무력증 등 희귀 자가면역질환 치료제 개발/상업화 경쟁사
- ArgenxCompetitor
FcRn 계열 등 중증 근무력증·자가면역질환 치료제 분야 핵심 경쟁사
About AN2 Therapeutics
- What technical signals does AN2 Therapeutics (ANTX) have?
- AN2 Therapeutics current technical signals: golden cross (5_20, 0d ago).
- Is AN2 Therapeutics a cup-and-handle pattern?
- No. AN2 Therapeutics has no valid Cup signal right now.
- What published figures are available for AN2 Therapeutics?
- Market cap: $156.47M. Trailing 12 months PER: -7.0×. Latest quarter PBR: 3.37×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about AN2 Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.